ENTRY       D11775                      Drug
NAME        Tarextumab (USAN/INN)
FORMULA     C6338H9804N1700O1990S48
EXACT_MASS  143106.4819
MOL_WEIGHT  143194.9764
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS SSGMSWVRQA PGKGLEWVSV IASSGSNTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARSI FYTTWGQGTL VTVSSASTKG
            PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSN FGTQTYTCNV DHKPSNTKVD KTVERKCCVE CPPCPAPPVA GPSVFLFPPK
            PKDTLMISRT PEVTCVVVDV SHEDPEVQFN WYVDGVEVHN AKTKPREEQF NSTFRVVSVL
            TVVHQDWLNG KEYKCKVSNK GLPAPIEKTI SKTKGQPREP QVYTLPPSRE EMTKNQVSLT
            CLVKGFYPSD IAVEWESNGQ PENNYKTTPP MLDSDGSFFL YSKLTVDKSR WQQGNVFSCS
            VMHEALHNHY TQKSLSLSPG K
            (Light chain)
            DIVLTQSPAT LSLSPGERAT LSCRASQSVR SNYLAWYQQK PGQAPRLLIY GASSRATGVP
            ARFSGSGSGT DFTLTISSLE PEDFAVYYCQ QYSNFPITFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H129-L215, H142-H198, H217-H'217, H218@H'218, H221-H'221, H224-H'224, H255-H315, H361-H419, H'22-H'96, H'129-L'215, H'142-H'198, H'255-H'315, H'361-H'419, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-Notch receptor antibody
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of cancer
TARGET      NOTCH2 [HSA:4853] [KO:K20994]
            NOTCH3 [HSA:4854] [KO:K20995]
  PATHWAY   hsa04330(4853+4854)  Notch signaling pathway
            hsa05200(4853+4854)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Notch signaling
                NOTCH2
                 D11775  Tarextumab (USAN/INN)
                NOTCH3
                 D11775  Tarextumab (USAN/INN)
DBLINKS     CAS: 1359940-55-8
            PubChem: 405226641
///
